UXARO-20
Rabeprazole (20mg) Injection
Manufactured at WHO-GMP certified facility by BIOFRIL HEALTHCARE. Available for hospital tender supply, Intensive Care Unit pharmacy, and Propaganda-cum-Distribution (PCD) franchise distribution across India.
UXARO-20 at a Glance
| Brand Name | UXARO-20 |
|---|---|
| Composition | Rabeprazole (20mg) Injection |
| Therapeutic Category | Pain / GI |
| Division | Critical Care Injectable |
| Pack / Presentation | Vial |
| Storage | Store below 25°C. Protect from light. |
| Manufacturer | BIOFRIL HEALTHCARE Pvt. Ltd. · WHO-GMP Plant, Nalagarh HP |
| Prescription Status | Schedule H — To be sold by retail on the prescription of a Registered Medical Practitioner only |
Indications & Clinical Applications
UXARO-20 (Rabeprazole (20mg) Injection) is indicated for the treatment of conditions in which Rabeprazole therapy is clinically appropriate, in accordance with the prescriber’s clinical judgement and current treatment protocols. For complete prescribing information, indications, dosing, contraindications, drug interactions, and adverse event profile, please refer to the official product insert and current pharmacopoeial guidance.
This page provides product identification information only. Clinical decisions and prescriptions must be made by a Registered Medical Practitioner based on the complete prescribing information and individual patient assessment.
Quality You Can Audit
- WHO-GMP certified manufacturing at our Nalagarh, Himachal Pradesh facility
- Certificate of Analysis (COA) issued with every batch dispatch
- ISO 9001:2015 Quality Management System
- Stability data conducted per ICH Q1A(R2) guidelines
- Hospital and institutional tender documentation prepared on request
- Available for PCD franchise distribution with monopoly district allocation
Submit Enquiry for UXARO-20
PCD franchise · Hospital tender supply · Bulk procurement · Distribution opportunities